[Therapeutic possibilities and clinical effects of IgE level modulation in allergic diseases].
Bobrowska
Monika
M
Oddział Kliniczny Interny Dzieciecej i Alergologii Instytutu Pediatrii Uniwersytetu Medycznego w Lodzi.
Stelmach
Iwona
I
D018926:Anti-Allergic Agents / Q000494:pharmacology*; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D061067:Antibodies, Monoclonal, Humanized; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy* / Q000276:immunology*; D007073:Immunoglobulin E / Q000187:drug effects*; D000069444:Omalizumab; D016896:Treatment Outcome
D018926:Anti-Allergic Agents; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab; D007073:Immunoglobulin E